PharmaCielo Ltd.
PCLOF
$0.02
$0.00-3.31%
OTC PK
| 09/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 176.92% | 221.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 176.92% | 221.38% | |||
| Cost of Revenue | 263.21% | -21.51% | |||
| Gross Profit | -721.41% | 167.93% | |||
| SG&A Expenses | 159.61% | 50.43% | |||
| Depreciation & Amortization | 143.45% | -46.76% | |||
| Other Operating Expenses | 74.03% | -788.89% | |||
| Total Operating Expenses | 236.21% | 21.70% | |||
| Operating Income | -262.26% | 5.91% | |||
| Income Before Tax | -7.01% | -4.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.01% | -4.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.01% | -4.84% | |||
| EBIT | -262.26% | 5.91% | |||
| EBITDA | -260.46% | 3.57% | |||
| EPS Basic | -8.00% | -4.72% | |||
| Normalized Basic EPS | -235.48% | -1.47% | |||
| EPS Diluted | -8.00% | -4.72% | |||
| Normalized Diluted EPS | -235.48% | -1.47% | |||
| Average Basic Shares Outstanding | 0.00% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||